About
Technology
Issues
FAQ
Links
Official Page
Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.